Schedule 13G ownership disclosure
ARALEZ PHARMACEUTICALS INC COM
Security class unavailable · CUSIP: 03852X100
Event date: 2016-03-17
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 5.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-16-012131
- Form type
- SC 13G
- Filer
- Aralez Pharmaceuticals Inc.
- CIK
- CIK 1660719
- Filed
- Mar 24, 2016
- Reporting period
- Mar 17, 2016
- Description
- Schedule 13G beneficial ownership